Buy Shree Cements; sell Sun Pharma, see lower levels in Tata Comm: Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Aditya Birla Nuvo has been in an uptrend so I am assuming that uptrend will continue. Shree Cements has been a remarkable performer. It has outperformed all cement companies. We do not talk about it but the chart is just going one way and there is a buying opportunity."

"My favourite Hindustan Unilever had a small three day correction perhaps there will be a resumption of that uptrend. I am also looking at short selling opportunities and one of them is Sun Pharmaceutical Industries. We had a sharp rally in Sun Pharma and we thought that the worst is over. However, it wasn't over. The rally has now been retraced almost completely so at best it will be choppy which means there will be opportunities to sell and make money on the downside. So Sun Pharma is a short sell," he said.

"Tata Communications is distributing on the charts and suggesting lower levels are coming. I wish I had taken some public sector undertaking (PSU) banks in my list. My only problem was that after that big rally I can only buy when they consolidate but the theme is intact."

"Lupin's charts are weak, so stay away," he added.